IN2014DN08260A - - Google Patents

Download PDF

Info

Publication number
IN2014DN08260A
IN2014DN08260A IN8260DEN2014A IN2014DN08260A IN 2014DN08260 A IN2014DN08260 A IN 2014DN08260A IN 8260DEN2014 A IN8260DEN2014 A IN 8260DEN2014A IN 2014DN08260 A IN2014DN08260 A IN 2014DN08260A
Authority
IN
India
Prior art keywords
telaprevir
solvate
preparation
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
Other languages
English (en)
Inventor
Wolfgang Felzmann
Stefanie Brunner
Thorsten Wilhelm
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IN2014DN08260A publication Critical patent/IN2014DN08260A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN8260DEN2014 2012-03-16 2013-03-15 IN2014DN08260A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12159923 2012-03-16
PCT/EP2013/055397 WO2013135870A1 (en) 2012-03-16 2013-03-15 Process for the synthesis of telaprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof

Publications (1)

Publication Number Publication Date
IN2014DN08260A true IN2014DN08260A (pl) 2015-05-15

Family

ID=47884350

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8260DEN2014 IN2014DN08260A (pl) 2012-03-16 2013-03-15

Country Status (4)

Country Link
US (1) US20150038677A1 (pl)
EP (1) EP2825534A1 (pl)
IN (1) IN2014DN08260A (pl)
WO (1) WO2013135870A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004501191A (ja) * 2000-06-28 2004-01-15 テバ ファーマシューティカル インダストリーズ リミティド カルベジロール
US8399615B2 (en) 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
SI2194043T1 (sl) 2005-08-19 2014-04-30 Vertex Pharmaceuticals Incorporated Postopki

Also Published As

Publication number Publication date
WO2013135870A1 (en) 2013-09-19
EP2825534A1 (en) 2015-01-21
US20150038677A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
MD20150091A2 (ro) Compuşi antivirali
PH12014502605A1 (en) Uracyl spirooxetane nucleosides
EP2938616A4 (en) PROCESS FOR THE PREPARATION OF TOFACITINIB AND INTERMEDIATES
PL2791093T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
MX361653B (es) Procedimiento para la preparación de derivados del ácido biliar.
IN2015DN00598A (pl)
PH12016501462A1 (en) Neprilysin inhibitors
WO2014125506A3 (en) A process for the preparation of ivacaftor and its intermediates
MX369662B (es) Granulos de harina de microalgas y proceso de preparacion de estos.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2012137227A3 (en) Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof
HUP1300647A2 (hu) Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
WO2013168176A3 (en) Process for preparation of fosaprepitant and salt thereof
IN2015DN00950A (pl)
ZA201803105B (en) Industrial process for the preparation of (5s,10s)-10-benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium (e)-3-carboxyacrylate salt
PH12018500872A1 (en) Innovative preparation and crystallization of iosimenol
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
IN2014DN09451A (pl)
EP3337790A4 (en) PROCESS FOR THE PREPARATION OF HYDROXYMETHYL FURFURAL DERIVATIVES
HK1223334A1 (zh) 製造植入物或該植入物的中間產品的方法以及通過該方法獲得的植入物和中間產品
MX2017008076A (es) DERIVADOS DE IMIDAZOPIRIDAZINA ENLAZADOS A HETEROCICLILO COMO INHIBIDORES DE PI3Kß.
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
ZA201307451B (en) Acadesine derivatives, products and compositions including same,therapeutic uses thereof and methods for synthesizing same
WO2014030173A3 (en) Improved process for preparation of atazanavir bisulfate
WO2014102759A3 (en) Process for the preparation of dasatinib and its intermediates